Human exposure to heterocyclic aromatic
amines (HAA) usually occurs through mixtures rather than individual compounds. However, the toxic effects and related mechanisms of co-exposure to HAA in humans remain unknown. We compared the effects of two of the most common HAA, 2-amino-1-methyl-6-phenylimidazo[4,5-
b]pyridine (
PhIP) and 2-amino-3,8-dimethylimidazo[4,5-f]
quinoxaline (MeIQx), individually or in combination, in the metabolically competent human
hepatoma HepaRG cells. Various endpoints were measured including cytotoxicity, apoptosis, oxidative stress and DNA damage by the comet assay. Moreover, the effects of
PhIP and/or MeIQx on
mRNA expression and activities of
enzymes involved in their activation and detoxification pathways were evaluated. After a 24h treatment,
PhIP and MeIQx, individually and in combination, exerted differential effects on apoptosis, oxidative stress, DNA damage and
cytochrome P450 (CYP) activities. Only
PhIP induced DNA damage. It was also a stronger inducer of
CYP1A1 and CYP1B1 expression and activity than MeIQx. In contrast, only MeIQx exposure resulted in a significant induction of
CYP1A2 activity. The combination of
PhIP with MeIQx induced an oxidative stress and showed synergistic effects on apoptosis. However,
PhIP-induced genotoxicity was abolished by a co-exposure with MeIQx. Such an inhibitory effect could be explained by a significant decrease in
CYP1A2 activity which is responsible for
PhIP genotoxicity. Our findings highlight the need to investigate interactions between HAA when assessing risks for human health and provide new insights in the mechanisms of interaction between
PhIP and MeIQx.